ARCHIVES

November issue of Business & Regulatory Report included.

This article is from The Cancer Letter archive.

Vol. 29 No. 44 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992